Evidence map›Paper›PMID 37576637›Full record

ArticleACS omega2023

Exploring the Therapeutic Effects of Multifunctional

Xuelin Li, Shuzhi Wang, Shan Duan, Lin Long, Linsheng Zhuo, Yan Peng, Yongxia Xiong, Shuang Li, Xue Peng, Yiguo Yan and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. ACS omega · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xuelin LiSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.ORCID https://orcid.org/0000-0001-8510-9387
Shuzhi WangSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Shan DuanThe First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Lin LongSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Linsheng ZhuoSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Yan PengSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Yongxia XiongSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Shuang LiSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Xue PengSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Yiguo YanThe First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Zhen WangSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.ORCID https://orcid.org/0000-0003-4134-1779
Weifan JiangSchool of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. Neuroinflammation and oxidative stress play an important role in the whole course of PD, which have been the focus of PD drug development. In our previous research, a series of

Identifiers

PMID37576637
PMCPMC10413456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.